Thank you Manhattan Institute for coming to cspan. We are going to leave this washington journal discussion here, a reminder that you can watch all of our programs online at cspan. Org. Live now to a conversation with joint chiefs of staff general joseph dunford. Hell be talking about National Security threats facing the u. S. Live coverage from the Brookings Institution here on cspan 3. General dunford and i have known each other for many years since we were captains, in fact. I can say with complete certainty that he is one of the finest marines to have been minted in the modern era of the marine corps. In 1996 Lieutenant Colonel dunford would take command of marines at camp lejeune in north carolina. Years later in kabul we would repeat that. His storied career spans more than four decades of Brilliant Service to our country and to the world. In peace and in crisis and in war. And as the u. S. Navigates multiple crises as we sit here this morning, i can think of no one, no one bette
the subcommittee on defense appropriations to the united states senate will come to order. today we are receiving an update on military readiness and defense budget matters we are pleased to welcome to the committee the secretary of defense and the chairman of the joint chiefs of staff. fiscal year 2017 department of defense appropriations agreement i look forward to completing the work of that bill in the coming weeks. we are well into the fiscal year and members of the subcommittee understand that legislation as we complete our work of the 2017 appropriation agreement, we also recognize request for additional appropriations fiscal year 2017 that has been submitted to congress. we welcome comments from the panel as well as the submission on 2018. did is an honor judge the secretary of defense before us with his first appearance as secretary. i am pleased to welcome back to the chairman of the joint chiefs of staff before the committee. with the forward to hearing more about
eastern this morning, that s literally seconds away. you can watch all the proceedings on our companion network, c-span. right now we re taking you to a national press club event from yesterday with the ceo of pfizer. this is c-span3 2. [inaudible conversations] good afternoon, ladies and gentlemen. for those of you who are just now tuning in and our television audience, our public radio audience and on the internet, welcome to the national press club. where since 1908 we have been the embodiment of the constitution. before we get started, i want to remind our guests here in the audience of some housekeeping rules, those of you who may have come in a little late. please put your phones on, at least on vibrate because we know you want to tweet, and we want you to follow the action. and so on twitter follow us on that,@press club dc and use the hashtagging npc live. and i want to introduce the head table. so as i introduce each of you, please stand, and i will briefly, as
[inaudible conversation] good afternoon ladies and gentlemen. for those of you who are just tuning in and our television audience in public radio audience and on the internet, welcome to the national press club. since 1908 we have been the embodiment of the constitution. before we get started, i want to remind our guests in the audience of some housekeeping roles. those of you who may have come in late, please put your phones on vibrate because we know you want to tweak. we want you to follow the action and so on twitter you can follow us at press club d.c. and using # npc life. i want to introduce the head table. as i introduce each of you, please stand and briefly as your name is announced, it will be from my left and you re right. senior reporter and treasurer of the national press club. michelle is the membership secretary of the national press club. sally is the executive vice president of corporate affairs at pfizer. and breaking news editor at usa today in a past mem
those receiving a liver transplant. an average expected lifetime patient cost to treat all stages was $205,000. approximately. compare these costs to the fact that more than 90% of the patients with the most common form of this can expected to be toward with this drug in as little as eight weeks. now as a lifetime cost slightly more than $40,000. and because of intense competition, the cost is now 50% less than the initial cost it was launched at. let us look at the returns of the industry. i think there are many ways that we can put the pharmaceutical industry we can point out the benefit to society. the various ways of looking at it. the transparency we are seeing in most states is not inappropriate way of measuring the benefit of the pharmaceutical industry. the drugs developed. when the drug is approved it, it only has half of its patent life left. patent is expired, it is broadly available in the form of generics. pharmaceuticals on prescripti